Matinas Biopharma Holdings Inc

ASE:MTNB  
0.72
+0.05 (+8.24%)
Earnings Announcements

Matinas Biopharma Reports First Quarter 2022 Financial Results And Operational Highlights

Published: 05/12/2022 10:38 GMT
Matinas Biopharma Holdings Inc (MTNB) - Matinas Biopharma Reports First Quarter 2022 Financial Results and Operational Highlights.
Qtrly Net Loss of $0.03 per Share.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.04

More details on our Analysts Page.